bifidobacterium lactis

Cell therapyexperimental

Bifidobacterium animalis is a gram-positive, anaerobic, rod-shaped bacterium of the Bifidobacterium genus which can be found in the large intestines of most mammals, including humans. — Wikipedia

Clinical trial activity

34 trials · 51 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
8
Phase 3
4
Phase 4
1

Earliest trial started Mar 1, 2008 (NCT00645996)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bifidobacterium lactis hn019
  • bifidobacterium-lactis hn019
  • bifidobacterium lactis w51
  • b. lactis
  • b. lactis hn019
  • b. lactis uabla-12

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06643299Phase 2Dec 31, 2024Rush University
NCT06754228N/ANov 13, 2024Natural Immune Systems Inc
NCT06148714N/ADec 1, 2023Citruslabs, Maneuver Marketing
NCT06871540N/AOct 1, 2023Inonu University
NCT07100743N/AApr 3, 2023B-Crobes Marketing (M) Sdn Bhd, National University of Malaysia
NCT05564767N/AOct 17, 2022Chr Hansen, Clinical Research Australia
NCT05416151N/AMay 24, 2022Danone Research, EURAXI Pharma
NCT05001997N/ASep 30, 2021University of Central Lancashire
NCT05064930N/ASep 1, 2021Medical University of Lublin, Nordic Bioscience
NCT04886778N/AJun 1, 2021Southern Medical University, Zhujiang Hospital
NCT04659408N/AMar 1, 2021Swiss Paraplegic Centre Nottwil
NCT04988594N/AFeb 1, 2021Faculty of Medical Science, Paraguay, Faculty of Medical Sciences, Clinical Hospital, Universidad de Cordoba
NCT04742322Phase 2Jan 11, 2021Universidade do Extremo Sul Catarinens
NCT04420676N/AAug 31, 2020Medical University of Graz
NCT04828421N/AJul 17, 2020Universidad de Almeria
NCT04231162N/AMar 31, 2020Danisco, Pasteur Merieux
NCT04366089Phase 2Mar 26, 2020University of Roma La Sapienza
NCT03959722N/AOct 31, 2019Hogeschool Leiden, University of Applied Sciences, Leiden University, University of Amsterdam, Wageningen University, Winclove Bio Industries BV
NCT03640065Phase 4Oct 20, 2019Cairo University
NCT04155801N/AOct 11, 2019Bausch Health Companies
Showing 20 of 34 trials
Page 1 / 2

Organizations

Research & Development (51)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
DaniscoFor profit4232009
Medical University of GrazAcademic/Hospital4412015
Fonterra Research CentreFor profit3312009
Sprim ConsultingFor profit2012009
Winclove Bio Industries BVFor profit2012018
Accurate Clinical Research, Houston, TXFor profit1012009
Bausch Health CompaniesFor profit1112019
B-Crobes Marketing (M) Sdn BhdFor profit1012023
Cairo UniversityAcademic/Hospital1112019
Capital Digestive Care, LLCAcademic/Hospital1012012
Chinese Academy of Medical SciencesAcademic/Hospital1112019
Chr HansenFor profit1112022
CitruslabsFor profit1012023
Clinical Research AustraliaAcademic/Hospital1012022
Danone ResearchFor profit1112022
DuPontFor profit1012012
EURAXI PharmaFor profit1012022
EurofinsFor profit1012014
Faculty of Medical Science, ParaguayAcademic/Hospital1012021
Faculty of Medical Sciences, Clinical HospitalAcademic/Hospital1112021
51 organizations
Page 1 / 3